39 related articles for article (PubMed ID: 19066290)
1. Inter-species variation in monovalent anion substrate selectivity and inhibitor sensitivity in the sodium iodide symporter (NIS).
Concilio SC; Zhekova HR; Noskov SY; Russell SJ
PLoS One; 2020; 15(2):e0229085. PubMed ID: 32084174
[TBL] [Abstract][Full Text] [Related]
2. Sodium/Iodide Symporter Metastable Intermediates Provide Insights into Conformational Transition between Principal Thermodynamic States.
Chakrabarti M; Amzel LM; Lau AY
J Phys Chem B; 2023 Feb; 127(7):1540-1551. PubMed ID: 36758032
[TBL] [Abstract][Full Text] [Related]
3. Dysidenin from the Marine Sponge
Ramage KS; Taki AC; Lum KY; Hayes S; Byrne JJ; Wang T; Hofmann A; Ekins MG; White JM; Jabbar A; Davis RA; Gasser RB
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940697
[TBL] [Abstract][Full Text] [Related]
4. Exploration of marine natural resources in Indonesia and development of efficient strategies for the production of microbial halogenated metabolites.
Yamazaki H
J Nat Med; 2022 Jan; 76(1):1-19. PubMed ID: 34415546
[TBL] [Abstract][Full Text] [Related]
5. Screening for Small Molecule Inhibitors of BMP-Induced Osteoblastic Differentiation from Indonesian Marine Invertebrates.
Yamazaki H; Ohte S; Rotinsulu H; Wewengkang DS; Sumilat DA; Abdjul DB; Maarisit W; Kapojos MM; Namikoshi M; Katagiri T; Tomoda H; Uchida R
Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33265937
[TBL] [Abstract][Full Text] [Related]
6. Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma.
Brito AF; Abrantes AM; Teixo R; Pires AS; Ribeiro AC; Ferreira RF; Mascarenhas A; Puga T; Laranjo M; Caramelo F; Boin I; Jefferson DM; Gonçalves C; Martins R; Tavares I; Ribeiro IP; Sarmento-Ribeiro AB; Carreira IM; Souza D; Tralhão JG; Botelho MF
Int J Oncol; 2020 Mar; 56(3):709-727. PubMed ID: 31922240
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule inhibitors of sodium iodide symporter function.
Lecat-Guillet N; Merer G; Lopez R; Pourcher T; Rousseau B; Ambroise Y
Chembiochem; 2008 Apr; 9(6):889-95. PubMed ID: 18307189
[TBL] [Abstract][Full Text] [Related]
8. Enhanced iodide sequestration by 3-biphenyl-5,6-dihydroimidazo[2,1-b]thiazole in sodium/iodide symporter (NIS)-expressing cells.
Lecat-Guillet N; Ambroise Y
ChemMedChem; 2008 Aug; 3(8):1211-6. PubMed ID: 18470848
[TBL] [Abstract][Full Text] [Related]
9. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
Dohán O; Carrasco N
Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
11. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
12. Characterization of small-molecule inhibitors of the sodium iodide symporter.
Lindenthal S; Lecat-Guillet N; Ondo-Mendez A; Ambroise Y; Rousseau B; Pourcher T
J Endocrinol; 2009 Mar; 200(3):357-65. PubMed ID: 19066290
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
